First Tracks Biotherapeutics Inc

TRAX | NASDAQ

Price Alert Chart Builder DCF Calculator

$45.08

-$0.15 (-0.32%)

At close: Oct 30, 2026, 4:00 PM ET

$45.50

+$0.42 (+0.93%)

Pre-market: Nov 2, 2026, 7:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.62B

Enterprise Value $1.46B

Beta 3.37

Average Volume 872.91K

Shares Outstanding (Diluted) 35.39M

Shares Change YoY N/A

Institutional Ownership 98.85%

Exchange NASDAQ

ISIN US3371851029

Price Performance

Price Change 1M 27.2%

Price Change 3M 2.4%

Price Change 6M 101.4%

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 16.8%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR 358.8%

Valuation

PE Ratio -18.86

Forward PE N/A

PEG Ratio -0.12

Forward PEG 0.82

PS Ratio N/A

Forward PS N/A

PB Ratio 9.59

P/FCF Ratio -25.09

P/Adj. FCF Ratio -21.29

P/OCF Ratio -15.49

EV/Sales N/A

EV/EBIT -16.58

EV/EBITDA -16.65

EV/FCF -22.55

Earnings Yield -5.3%

FCF Yield -4.0%

Adj. FCF Yield -4.7%

Financial Health

Net Cash $165.58M

Total Debt $4.33M

Cash & Short-Term Investments $168.02M

Total Assets $183.14M

Current Ratio 14.28

Quick Ratio 14.28

Debt / Equity Ratio 0.03

Debt / EBITDA -0.05

Debt / FCF -0.07

OCF / Debt -14.88

Interest Coverage 0.00

Altman Z-Score 78.55

Piotroski F-Score 0

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -17.8%

Returns

Return on Assets -69.0%

Return on Equity -53.1%

Return on Invested Capital -77.2%

Return on Capital Employed -78.3%

Return on Tangible Assets -69.0%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 9

EPS Growth Next 3Y -21.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.92

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $71.33

Price Target Upside 58.2%

Cash Flow

Operating Cash Flow $-64.48M

Free Cash Flow $-64.52M

Adj. Free Cash Flow $-76.02M

FCF Per Share -$2.92

OCF Per Share -$2.91

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-207K

Operating Income $-87.75M

EBITDA $-87.42M

Net Income $-83.86M

EPS (Diluted) -$2.39

Revenue / Employee N/A

Profit / Employee $-806.33K

Employees 104